PO-0711: Relating CT image heterogeneity to patient outcome in the SCOPE 1 oesophageal cancer trial  by Carrington, R. et al.
S332                                                                                                                                                    ESTRO 35 2016 
______________________________________________________________________________________________________ 
Purpose or Objective: In pancreatic cancer, the delineation 
of target volumes on a CT scan can be difficult due to poor 
contrast between tumour and surrounding tissues. This study 
quantifies, for pancreatic cancer in the Netherlands, the 
interobserver variation of delineated gross tumour volume 
(GTV) and the internal GTV (iGTV: the volume encompassing 
GTV in all ten phases of the respiratory cycle) on three-
dimensional CT (3DCT) and four-dimensional-CT (4DCT), 
respectively. 
 
Material and Methods: Seven radiation oncologists from six 
institutions, with an average of 5 irradiated pancreatic 
patients per year (range: 3–10), delineated pancreatic 
tumours in four patients with (borderline) resectable 
pancreatic cancer. First, the GTV was delineated on a 
contrast-enhanced 3DCT under guidance of an arterial and 
venous contrast-enhanced diagnostic scan. This contrast-
enhanced 3DCT scan was obtained during free breathing, 
using a GE LightSpeed RT16 scanner. The GTV was expanded 
with a fixed margin of 5 mm to create the CTV. In the same 
session, a 4DCT scan, without contrast enhancement, was 
obtained, during which the respiratory motion of the patient 
was monitored to reconstruct 10 respiratory phase scans. 
Second, the iGTV was delineated on the 4DCT, under 
guidance of the diagnostic CT and expanded with a fixed 
margin of 5 mm to create an iCTV. Also, a questionnaire 
concerning experience of the participating radiation 
oncologists was filled out. We calculated median volumes, 
encompassing volumes and common volumes of the GTV, 
iGTV, CTV and iCTV. In addition, the generalized conformity 
index (CIgen) and overall observer variation were calculated 
(value of 1 representing full agreement; 0 no agreement). 
Interobserver variation of 3DCT and 4DCT delineations were 
analysed and compared. 
 
Results: For all delineated and created volumes, the results 
of the mean median volumes, encompassing volumes, 
common volumes and CIgen over all four patients are 
presented in Table 1. The mean overall standard deviation 
(SD) (averaged over 4 patients) was 0.54 cm and 0.58 cm on 
3DCT and 4DCT, respectively. The CIgen was smaller for 
4DCT, indicating larger variations in delineation on 4DCT. 
Typical differences in delineations between the seven 
observers are presented in Fig. 1. The radiation oncologists 
experienced the GTV and iGTV delineations in this study as 
difficult. 
 
 
 
 
Conclusion: A considerable interobserver variation in 
delineation of pancreatic tumours was found, with a mean 
CIgen of 0.46 for 3DCT (GTV) and 0.35 for 4DCT (iGTV). This 
indicates a large variation in interpretation of diagnostic CT 
images and 4DCT images. The limited experience of the 
observers with delineation as well as the poor contrast 
between pancreatic cancer and surrounding tissues on CT 
imaging may have contributed to these results. This should 
be improved, perhaps by using additional imaging. 
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Purpose or Objective: Heterogeneity is a well recognised 
feature of malignancy that has been associated with adverse 
tumour biology (1). There is also initial evidence that it may 
be a potential prognostic biomarker for oesophageal cancer 
(2). Using texture analysis, the purpose of this study is to 
investigate the relationship between CT image heterogeneity 
and patient outcome in the SCOPE 1 UK wide multi-centre 
clinical trial on oesophageal cancer.  
 
 
 
Material and Methods: The planning CT images of 215 
patients from the SCOPE 1 clinical trial were uploaded to the 
TexRAD texture analysis software package. The original GTV 
outlines from the trial were imported on to the relevant 
DICOM CT images for each patient. Outcome data from the 
trial (Overall survival (OS) and progression free survival (PFS)) 
was included for analysis. Texture analysis of the area within 
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the GTV was undertaken on the images to quantify entropy, 
uniformity, mean grey-level intensity, kurtosis, standard 
deviation of histogram and skewness for fine to coarse 
textures (filters: 0.0-6.0). 
 
 
 
Results: To date, 23 patients from 21 centres entered in the 
trial have been analysed. Mean Grey Level <399.745, 
Skewness >2.215, Kurtosis >0.6 were associated with 
improved PFS (p=0.0227, p=0.0218, p=0.0460 respectively) 
for medium filter 3.0. For filter 4.0, improved PFS was 
associated with Mean Grey Level <454.055 (p=0.0227) and 
Skewness >0.840 (p=0.0371). Mean Grey Levels of <565.535 
(p=0.0251) and <542.5(p=0.0251) were associated with 
improved PFS for filters 5.0 and 6.0 respectively. For OS, 
mean grey levels of <34.845 (p=0.0182), <399.745 (p=0.0381) 
and <454.055 (p=0.0381) were associated with improved 
survival for filters 0.0, 3.0 and 4.0 respectively. An entropy 
level <5.6 was also found to be significant (p=0.0428) for 
improved overall survival using filter 2.0. 
 
Conclusion : Normal 0 false false false EN-GB JA X-NONE  
We have shown using a 10% sample of the overall database 
available that CTimage heterogeneity factors are associated 
with PFS and OS for patients frommultiple centres. 
Preliminary results therefore suggest that in the future itmay 
be possible to make clinical treatment decisions based on the 
CT imageheterogeneity of a tumour volume. This will be 
confirmed by completing analysison the whole SCOPE 1 
database. 
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Purpose or Objective: To evaluate the feasibility and clinical 
results of stereotactic body radiation therapy (SBRT) in the 
treatment of hepatocellular carcinoma (HCC) in patients 
unsuitable or failing to standard loco-regional therapies. 
 
Material and Methods: Patients with < 3 inoperable HCC 
lesions with < 6 cm diameter were treated with SBRT. 
Prescription dose was adapted according to tumor size and 
global liver function and comprised 48-36 Gy in 3 fractions or 
40 Gy in 5 fractions (prescribed on 80 % isodose). Primary 
endpoint included in-field (LC) local control and toxicity. 
Secondary endpoints were overall (OS), cancer-specific (CSS) 
and progression-free survival (PFS). 
 
Results: 82 patients with 120 HCC lesions were treated. 
Median age was 70 (range 44-90). Most of the patients had 
Child-Pugh A5-A6 cirrhosis (80.4%), Barcelona Clinic Liver 
Cancer classification 0-A-B (93%). Median lesion size was 22 
mm (range 7-120 mm). Most lesion were in the left lobe 
(65%). In most patients SBRT was the first local treatment 
(82%). Up to 7% of patients had portal vein thrombosis. 
Median observation time was 14 months. Actuarial 1-year LC, 
PFS, CSS and OS were 76.7% (95%CI:40-92.5%), 13.5% 
(95%CI:4.9-26-4), 92.1% (95%CI:81.8-96.7%) and 78% 
(95%CI:66.4-86%), respectively. Up to 18 patients (22%) 
experienced G3-G4 acute toxicity and 1 case of G5 toxicity 
was reported. Four cases of classical Radiation-induced liver 
disease (RILD) were reported, while 21 patients experienced 
a modification of Child-Pugh classification (25%), mostly of 2-
3 points. On multivariate analysis, no factors were predictive 
for LC while initial Child-Pugh class and > 2 points Child-Pugh 
classification modification predicted for OS and CSS. 
 
 
Conclusion: SBRT is a safe and effective treatment option for 
inoperable HCC, with acceptable LC rate and toxicity profile. 
Limiting toxic events may have prognostic significance. 
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